Deerfield Management Portfolio
Growth & qualityDEERFIELD MANAGEMENT COMPANY, L.P. 13F holdings · Q3 2026 vs Q2 2026
Why growth & quality: 75 holdings, 14 effective · top 10 59% · turnover 16% a quarter · earnings yield -6.3% (median 2.9%) · 111 quarters of 13Fs
- 13F value
- $6.5bn−32.5% vs $9.6bn in Q2 2026
- Holdings
- 63 7 new · 10 sold out
- Top 10 weight
- 37.7% Largest: RVMD 6.7%
- Bought est.
- $545m New positions and adds
- Sold est.
- $792m Trims and exits
- Quarter
- Q3 2026 Filed
Largest trades since Q2 2026
Estimated dollars: the change in shares times the quarter-end price the filing implies. Exits use last quarter's value.
| Action | Stock | Shares | Est. traded | Weight | Other gurus |
|---|---|---|---|---|---|
| Trimmed | VTRSVIATRIS INC | −45.9% | −$164m | 3.3% → 3.0% | 6 |
| Sold out | LNTHLANTHEUS HLDGS INC | −100.0% | −$84m | 0.9% → 0.0% | — |
| Added | CHECHEMED CORP NEW | +506.7% | +$77m | 0.1% → 1.4% | 1 |
| Added | CELCCELCUITY INC | +65.2% | +$75m | 1.6% → 2.9% | 4 |
| Sold out | PFEPFIZER INC | −100.0% | −$73m | 0.8% → 0.0% | — |
| Sold out | SUPNINDIVIOR PHARMACEUTICALS INC | −100.0% | −$68m | 0.7% → 0.0% | — |
| Sold out | CDNACAREDX INC | −100.0% | −$57m | 0.6% → 0.0% | — |
| Trimmed | ACHCACADIA HEALTHCARE COMPANY IN | −44.8% | −$56m | 1.4% → 1.1% | 2 |
| Trimmed | RVMDREVOLUTION MEDICINES INC | −11.2% | −$55m | 4.7% → 6.7% | 8 |
| Added | UTHRUNITED THERAPEUTICS CORP DEL | +18.3% | +$45m | 2.6% → 4.5% | 3 |
| New | ZTSZOETIS INC | New | +$44m | 0.0% → 0.7% | 18 |
| Added | BMRNBIOMARIN PHARMACEUTICAL INC | +51.9% | +$42m | 0.8% → 1.9% | 3 |
| Added | BSXBOSTON SCIENTIFIC CORP | +62.4% | +$36m | 0.6% → 1.4% | 15 |
| Trimmed | ARWRARROWHEAD PHARMACEUTICALS IN | −39.3% | −$36m | 1.2% → 0.9% | 4 |
| New | COOCOOPER COS INC | New | +$31m | 0.0% → 0.5% | 5 |
| Added | COGTCOGENT BIOSCIENCES INC | +19.0% | +$30m | 2.0% → 3.0% | 7 |
| Added | IONSIONIS PHARMACEUTICALS INC | +34.4% | +$30m | 1.6% → 1.8% | 4 |
| Sold out | SIONSIONNA THERAPEUTICS INC | −100.0% | −$30m | 0.3% → 0.0% | — |
| Trimmed | BLTEBELITE BIO INC | −46.8% | −$28m | 0.6% → 0.5% | 2 |
| Trimmed | IDYAIDEAYA BIOSCIENCES INC | −26.2% | −$27m | 1.1% → 1.2% | 1 |
| New | BLSMBLOSSOMHILL THERAPEUTICS INC | New | +$27m | 0.0% → 0.4% | 1 |
| Added | TNGXTANGO THERAPEUTICS INC | +23.6% | +$25m | 1.4% → 2.0% | 7 |
| New | TNDMTANDEM DIABETES CARE INC | New | +$23m | 0.0% → 0.4% | 1 |
| Sold out | ALNYALNYLAM PHARMACEUTICALS INC | −100.0% | −$20m | 0.2% → 0.0% | — |
| Trimmed | DNTHDIANTHUS THERAPEUTICS INC | −18.8% | −$19m | 1.1% → 1.2% | 5 |
| Sold out | KYTXKYVERNA THERAPEUTICS INC | −100.0% | −$18m | 0.2% → 0.0% | — |
| Trimmed | MNPRMONOPAR THERAPEUTICS INC | −57.5% | −$15m | 0.3% → 0.2% | 2 |
| New | VOGXVOGENX INC | New | +$14m | 0.0% → 0.2% | 0 |
| Added | VERAVERA THERAPEUTICS INC | +10.8% | +$14m | 1.8% → 2.2% | 2 |
| Sold out | SGPSPYGLASS PHARMA INC | −100.0% | −$12m | 0.1% → 0.0% | — |
| Added | BBNXBETA BIONICS INC | +43.8% | +$11m | 0.2% → 0.6% | 2 |
| New | ALHCALIGNMENT HEALTHCARE INC | New | +$9.6m | 0.0% → 0.1% | 1 |
| Sold out | MOBIMOBIA MED INC | −100.0% | −$9.0m | 0.1% → 0.0% | — |
| New | ETRAELECTRA THERAPEUTICS INC | New | +$7.9m | 0.0% → 0.1% | 2 |
| Trimmed | BBOTBRIDGEBIO ONCOLOGY THERAPEUT | −35.8% | −$7.2m | 0.4% → 0.2% | 1 |
| Trimmed | TYRATYRA BIOSCIENCES INC | −28.0% | −$6.2m | 0.3% → 0.2% | 5 |
| Sold out | VCYTVERACYTE INC | −100.0% | −$5.9m | 0.1% → 0.0% | — |
| Added | BCRXBIOCRYST PHARMACEUTICALS INC | +2.6% | +$3.3m | 1.6% → 2.0% | 4 |
| Trimmed | DRUGBRIGHT MINDS BIOSCIENCES INC | −16.5% | −$2.3m | 0.2% → 0.2% | 1 |
All holdings 63 identified, plus $1.5bn in securities without a listed ticker
Click a column to sort. Values are as reported at quarter-end, not today's prices.
| # | Stock | Shares | ||||
|---|---|---|---|---|---|---|
| 1 | RVMDREVOLUTION MEDICINES INC | $436m | 2,124,000 | −11.2% | 8 | |
| 2 | CNCCENTENE CORP DEL | $304m | 4,901,000 | Unchanged | 6 | |
| 3 | UTHRUNITED THERAPEUTICS CORP DEL | $293m | 540,598 | +18.3% | 3 | |
| 4 | PRAXPRAXIS PRECISION MEDICINES I | $281m | 963,351 | Unchanged | 5 | |
| 5 | GMABGENMAB A/S | $245m | 6,865,000 | Unchanged | 1 | |
| 6 | VTRSVIATRIS INC | $194m | 10,938,000 | −45.9% | 6 | |
| 7 | COGTCOGENT BIOSCIENCES INC | $191m | 5,957,000 | +19.0% | 7 | |
| 8 | CELCCELCUITY INC | $191m | 2,397,664 | +65.2% | 4 | |
| 9 | LEGNLEGEND BIOTECH CORP | $162m | 8,137,638 | Unchanged | 2 | |
| 10 | VERAVERA THERAPEUTICS INC | $140m | 4,338,778 | +10.8% | 2 | |
| 11 | TNGXTANGO THERAPEUTICS INC | $129m | 5,180,000 | +23.6% | 7 | |
| 12 | BCRXBIOCRYST PHARMACEUTICALS INC | $129m | 15,490,928 | +2.6% | 4 | |
| 13 | BKDBROOKDALE SR LIVING INC | $126m | 11,637,032 | Unchanged | 3 | |
| 14 | BMRNBIOMARIN PHARMACEUTICAL INC | $122m | 2,025,146 | +51.9% | 3 | |
| 15 | IONSIONIS PHARMACEUTICALS INC | $119m | 2,660,669 | +34.4% | 4 | |
| 16 | LRMRLARIMAR THERAPEUTICS INC | $114m | 35,606,974 | Unchanged | 1 | |
| 17 | MLYSMINERALYS THERAPEUTICS INC | $99m | 3,958,000 | Unchanged | 3 | |
| 18 | BSXBOSTON SCIENTIFIC CORP | $93m | 2,135,440 | +62.4% | 15 | |
| 19 | CHECHEMED CORP NEW | $92m | 182,000 | +506.7% | 1 | |
| 20 | INSPINSPIRE MED SYS INC | $90m | 1,296,862 | Unchanged | — | |
| 21 | BIOBIO RAD LABS INC | $85m | 226,070 | Unchanged | 2 | |
| 22 | DNTHDIANTHUS THERAPEUTICS INC | $80m | 914,000 | −18.8% | 5 | |
| 23 | IDYAIDEAYA BIOSCIENCES INC | $77m | 2,003,000 | −26.2% | 1 | |
| 24 | SNDXSYNDAX PHARMACEUTICALS INC | $71m | 3,779,900 | Unchanged | 1 | |
| 25 | SVRASAVARA INC | $70m | 13,569,000 | Unchanged | 4 | |
| 26 | CERTCERTARA INC | $69m | 7,512,928 | Unchanged | 1 | |
| 27 | ACHCACADIA HEALTHCARE COMPANY IN | $69m | 2,493,589 | −44.8% | 2 | |
| 28 | AHCOADAPTHEALTH CORP | $65m | 11,477,730 | Unchanged | — | |
| 29 | PBLSPARABILIS MEDICINES INC | $61m | 1,880,704 | Unchanged | 5 | |
| 30 | XENEXENON PHARMACEUTICALS INC | $60m | 1,615,696 | Unchanged | 4 | |
| 31 | ARWRARROWHEAD PHARMACEUTICALS IN | $55m | 843,063 | −39.3% | 4 | |
| 32 | NVSTENVISTA HOLDINGS CORPORATION | $52m | 2,210,100 | Unchanged | — | |
| 33 | STOKSTOKE THERAPEUTICS INC | $47m | 1,823,500 | Unchanged | 4 | |
| 34 | ZTSZOETIS INC | $44m | 632,000 | New | 18 | |
| 35 | IRONDISC MEDICINE INC | $43m | 657,000 | Unchanged | 6 | |
| 36 | BBNXBETA BIONICS INC | $36m | 1,903,710 | +43.8% | 2 | |
| 37 | GPCRSTRUCTURE THERAPEUTICS INC | $34m | 1,086,000 | Unchanged | 5 | |
| 38 | SPRYARS PHARMACEUTICALS INC | $32m | 7,503,812 | Unchanged | 3 | |
| 39 | BLTEBELITE BIO INC | $32m | 190,000 | −46.8% | 2 | |
| 40 | COOCOOPER COS INC | $31m | 557,000 | New | 5 | |
| 41 | BLSMBLOSSOMHILL THERAPEUTICS INC | $27m | 1,446,000 | New | 1 | |
| 42 | ODTXODYSSEY THERAPEUTICS INC | $23m | 1,046,139 | Unchanged | 1 | |
| 43 | TNDMTANDEM DIABETES CARE INC | $23m | 1,390,909 | New | 1 | |
| 44 | STLNSTARLING ONCOLOGY INC | $21m | 3,360,052 | Unchanged | — | |
| 45 | AVLNAVALYN PHARMACEUTICALS INC | $21m | 731,000 | Unchanged | 5 | |
| 46 | ALMRALAMAR BIOSCIENCES INC | $20m | 600,000 | Unchanged | 1 | |
| 47 | TYRATYRA BIOSCIENCES INC | $16m | 732,392 | −28.0% | 5 | |
| 48 | FHTXFOGHORN THERAPEUTICS INC | $16m | 4,394,367 | Unchanged | 1 | |
| 49 | VOGXVOGENX INC | $14m | 635,707 | New | — | |
| 50 | EMBCEMBECTA CORP | $14m | 2,534,961 | Unchanged | 2 | |
| 51 | BBOTBRIDGEBIO ONCOLOGY THERAPEUT | $13m | 3,138,167 | −35.8% | 1 | |
| 52 | DRUGBRIGHT MINDS BIOSCIENCES INC | $12m | 236,295 | −16.5% | 1 | |
| 53 | MNPRMONOPAR THERAPEUTICS INC | $11m | 137,591 | −57.5% | 2 | |
| 54 | ALHCALIGNMENT HEALTHCARE INC | $9.6m | 1,172,418 | New | 1 | |
| 55 | ADAGADAGENE INC | $8.5m | 2,666,666 | Unchanged | — | |
| 56 | COAGHEMAB THERAPEUTICS HLDGS INC | $8.5m | 275,000 | Unchanged | 4 | |
| 57 | ETRAELECTRA THERAPEUTICS INC | $7.9m | 700,000 | New | 2 | |
| 58 | ANNXANNEXON INC | $2.5m | 583,913 | Unchanged | 1 | |
| 59 | ALECALECTOR INC | $2.0m | 1,055,192 | Unchanged | 3 | |
| 60 | EWEDWARDS LIFESCIENCES CORP | $1.2m | 13,702 | Unchanged | 6 | |
| 61 | MIRMMIRUM PHARMACEUTICALS INC | $515k | 6,027 | Unchanged | 8 | |
| 62 | HUMHUMANA INC | $350k | 917 | Unchanged | 6 | |
| 63 | PMVPPMV PHARMACEUTICALS INC | $15k | 8,790 | Unchanged | — |
Closest portfolios
Overlap is the weight two books have in common: for each shared stock, the smaller of the two weights, summed.
- Avoro Capital Advisors14.6%8 shared · RVMD, UTHR, VERA, CELC
- Paradigm Biocapital Advisors13.9%7 shared · RVMD, GMAB, TNGX, GPCR
- Baker Bros. Advisors13.7%16 shared · RVMD, PRAX, CELC, IDYA
- Perceptive Advisors12.8%9 shared · PRAX, CELC, RVMD, BCRX
- Farallon Capital Management10.0%8 shared · RVMD, BSX, ACHC, TNGX
- TCG Crossover Management9.7%10 shared · COGT, TNGX, BCRX, DNTH
- Bvf9.1%9 shared · RVMD, STOK, GPCR, IRON
- Rtw Investments8.1%11 shared · CELC, TNGX, COGT, STOK
- DME Capital Management7.2%4 shared · CNC, VTRS, BIO, ACHC
- Ra Capital Management4.4%11 shared · MLYS, PBLS, IRON, SPRY
Only here
The largest holdings no other tracked guru owns.
- INSPINSPIRE MED SYS INC1.4%
- AHCOADAPTHEALTH CORP1.0%
- NVSTENVISTA HOLDINGS CORPORATION0.8%
- STLNSTARLING ONCOLOGY INC0.3%
- VOGXVOGENX INC0.2%
- ADAGADAGENE INC0.1%
- PMVPPMV PHARMACEUTICALS INC0.0%
A 13F is a filing, not a live portfolio. It lists US-listed long stock positions at quarter-end, and it arrives up to 45 days later. Cash, shorts, bonds, options and foreign listings are not in it. Trade sizes here are estimates from the change in share count, restated for stock splits.
Snapshot refreshed